1,160
Views
0
CrossRef citations to date
0
Altmetric
News & Analysis

Research Spotlight: Bionanotechnology: Small can Have a Big Impact in the Medical Sciences: A Win-Win Situation. Part 1.

, &
Pages 1515-1522 | Published online: 13 Oct 2010

Figures & data

Figure 1. Research theme areas and research chairs at Waterloo Institute for Nanotechnology (WIN).

CRC: Canada Research Chair; IRC: Industrial Research Chair; NSERC: Natural Sciences and Engineering Research Council.

Figure 1. Research theme areas and research chairs at Waterloo Institute for Nanotechnology (WIN).CRC: Canada Research Chair; IRC: Industrial Research Chair; NSERC: Natural Sciences and Engineering Research Council.
Figure 2. The Quantum Nano Centre.

Reproduced with permission from KPMB Architects.

Figure 2. The Quantum Nano Centre.Reproduced with permission from KPMB Architects.
Figure 3. Atomic-force microscopic images of the compaction of plasmid DNA into nanoparticles by gemini surfactant 16–3–16.

(A)‘Naked’ plasmid. (B) Initial phases of compaction 30 s after adding gemini surfactant; bar 100 nm. (C) Nanoparticle formation 15 min after adding gemini surfactant; bars 400 nm.

Reproduced with permission from Citation[12].

Figure 3. Atomic-force microscopic images of the compaction of plasmid DNA into nanoparticles by gemini surfactant 16–3–16. (A)‘Naked’ plasmid. (B) Initial phases of compaction 30 s after adding gemini surfactant; bar 100 nm. (C) Nanoparticle formation 15 min after adding gemini surfactant; bars 400 nm.Reproduced with permission from Citation[12].
Figure 5. Time-course of intracellular delivery of siRNA by multiwall carbon nanotubes into murine PAM 212 keratinocytes.

Cell viability is indicated by calcein staining (green); siGLO-RNA uptake into cells is indicated by red.

Figure 5. Time-course of intracellular delivery of siRNA by multiwall carbon nanotubes into murine PAM 212 keratinocytes.Cell viability is indicated by calcein staining (green); siGLO-RNA uptake into cells is indicated by red.
Figure 4. Schematic (A) and transmission electron microscopic image (B) of a multiwall carbon nanotube (~15 nm outer diameter) synthesized using the SSP-354 benchtop chemical vapor deposition system by Nanotech Innovations.
Figure 4. Schematic (A) and transmission electron microscopic image (B) of a multiwall carbon nanotube (~15 nm outer diameter) synthesized using the SSP-354 benchtop chemical vapor deposition system by Nanotech Innovations.
Figure 6. Bacterioferritin and Peptide-Nanotube Interactions.

(A) Visualized internal cavity of bacterioferritin showing the nanoscale dimension of this class of protein. (B) Peptide–single-walled nanotube interaction based on various biophysical studies conducted by the Honek group.

Figure 6. Bacterioferritin and Peptide-Nanotube Interactions. (A) Visualized internal cavity of bacterioferritin showing the nanoscale dimension of this class of protein. (B) Peptide–single-walled nanotube interaction based on various biophysical studies conducted by the Honek group.
Figure 7. Particle size distributions and micrographs demonstrating the morphology change of unIonized di-end-capped C60-b-PAA83-b-C60 induced by the binding of TX100:

(A) CTX100 = 0 mM; (B) CTX100 = 0.7 mM; (C) CTX100 = 1.7 mM; (D) CTX100 = 3.5 mM.

Figure 7. Particle size distributions and micrographs demonstrating the morphology change of unIonized di-end-capped C60-b-PAA83-b-C60 induced by the binding of TX100: (A) CTX100 = 0 mM; (B) CTX100 = 0.7 mM; (C) CTX100 = 1.7 mM; (D) CTX100 = 3.5 mM.

Table 1. Researchers and research interests in nanobiotechnology at WIN.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.